Synthetic Toll-like receptor agonists for the development of powerful malaria vaccines: a patent review.

Arshpreet KaurDeepika KannanSurinder K MehtaShailja SinghDeepak B Salunke

Published in: Expert opinion on therapeutic patents (2018)

TLR agonists are promising adjuvants for the development of effective malaria vaccine, allowing for both innate inflammatory responses as well as the induction of adaptive immunity.

Keyphrases

toll like receptor
immune response
inflammatory response
nuclear factor
plasmodium falciparum